Canine leishmaniosis is an important vector‐borne zoonosis caused mainly by Leishmania
infantum. Diagnosis and treatment of affected individuals can be particularly complex …

Immune control of Leishmania infantum, the causative agent of most canine leishmaniosis
(CanL), requires a balancing act between inflammatory and regulatory responses. This …

Produced amidst the still rippling effects of a pandemic and as the world experiences the
increasing burden of global warming and a rapidly changing biosphere, the second edition …

Background Visceral leishmaniasis (VL) is a vector borne zoonotic disease endemic in
humans and dogs in Brazil. Due to the increased risk of human infection secondary to the …

Better tools are necessary to eliminate visceral leishmaniasis (VL). Modeling studies for
regional Leishmania elimination indicate that an effective vaccine is a critical tool. Dogs are …

Leishmaniosis due to Leishmania infantum is a complex infection that can affect both
humans and dogs, and present a wide range of clinical signs and clinicopathological …

Abstract Background Canine leishmaniosis (CanL) is a parasitic zoonotic disease, endemic
in the Mediterranean basin including Spain. While knowledge about CanL, its management …

Visceral Leishmaniasis is a deadly disease caused by Leishmania infantum, endemic in
more than 98 countries across the globe. Although the most common means of transmission …

Little progress was conducted concerning discovering new efficient antileishmanial drugs for
many years. Hence, the disease has become a global health problem meanwhile …

Abstract Background Domperidone (Leisguard®) is an immunomodulatory drug used as a
preventive measure in healthy dogs. However, no studies have been published in healthy …